Oncozenge AB banner
O

Oncozenge AB
STO:ONCOZ

Watchlist Manager
Oncozenge AB
STO:ONCOZ
Watchlist
Price: 5.8 SEK Market Closed
Market Cap: kr73.4m

Wall Street
Price Targets

ONCOZ Price Targets Summary
Oncozenge AB

Wall Street analysts forecast ONCOZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCOZ is 11.73 SEK with a low forecast of 11.62 SEK and a high forecast of 12.08 SEK.

Lowest
Price Target
11.62 SEK
100% Upside
Average
Price Target
11.73 SEK
102% Upside
Highest
Price Target
12.08 SEK
108% Upside
Oncozenge AB Competitors:
Price Targets
GRP
Greencoat Renewables PLC
22% Upside
GFS
Globalfoundries Inc
23% Upside

Revenue
Forecast

N/A
Past Growth
93% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
93% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Oncozenge AB's revenue for the next 1 year is 93%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONCOZ's stock price target?
Price Target
11.73 SEK

According to Wall Street analysts, the average 1-year price target for ONCOZ is 11.73 SEK with a low forecast of 11.62 SEK and a high forecast of 12.08 SEK.

What is Oncozenge AB's Revenue forecast?
Projected CAGR
93%

The compound annual growth rate of Oncozenge AB's revenue for the next 1 year is 93%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett